Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tove L J Eriksson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|December 16, 2006
Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergensGuro Gafvelin, Stephen Parmley, Theresa Neimert-Andersson, et al.
Journal of Molecular Biology|January 22, 2008
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody moleculeMikaela Friedman, Anna Orlova, Eva Johansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistryVladimir Tolmachev, Mikaela Friedman, Mattias Sandström, et al.
Immunology|September 24, 2004
A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitroTheresa N Andersson, Gunilla J Ekman, Hans Grönlund, et al.
Cancer Research|April 19, 2006
Tumor imaging using a picomolar affinity HER2 binding affibody moleculeAnna Orlova, Mikaela Magnusson, Tove L J Eriksson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|December 16, 2006
Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergensGuro Gafvelin, Stephen Parmley, Theresa Neimert-Andersson, et al.
Journal of Molecular Biology|January 22, 2008
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody moleculeMikaela Friedman, Anna Orlova, Eva Johansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistryVladimir Tolmachev, Mikaela Friedman, Mattias Sandström, et al.
Immunology|September 24, 2004
A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitroTheresa N Andersson, Gunilla J Ekman, Hans Grönlund, et al.
Cancer Research|April 19, 2006
Tumor imaging using a picomolar affinity HER2 binding affibody moleculeAnna Orlova, Mikaela Magnusson, Tove L J Eriksson, et al.
Pageof 1